Detalhe da pesquisa
1.
Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Breast Cancer Res
; 22(1): 91, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811538
2.
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Breast Cancer Res
; 24(1): 50, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841108
3.
Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
PLoS Med
; 14(4): e1002302, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28430777
4.
Advancing Immunotherapy in Metastatic Breast Cancer.
Curr Treat Options Oncol
; 18(6): 35, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28534250
5.
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
J Med Genet
; 53(12): 800-811, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595995
6.
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
PLoS Med
; 13(12): e1002204, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28027312
7.
Relevance of tumor-infiltrating lymphocytes in breast cancer.
BMC Med
; 13: 202, 2015 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26300242
8.
Oncogene addiction and immunity: clinical implications of tumour infiltrating lymphocytes in breast cancers overexpressing the HER2/neu oncogene.
Curr Opin Oncol
; 26(6): 562-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25188474
9.
Integrin linked kinase (ILK) is required for lens epithelial cell survival, proliferation and differentiation.
Exp Eye Res
; 121: 130-42, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24472646
10.
Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancer.
J Natl Cancer Inst
; 115(7): 805-814, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166471
11.
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 68, 2023 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582853
12.
Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.
Cancer Cell
; 41(3): 585-601.e8, 2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827978
13.
Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer.
Cancer Res
; 77(22): 6340-6352, 2017 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947417
14.
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.
Nat Commun
; 8(1): 606, 2017 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28928458
15.
Molecular segmentation of luminal breast: Reality in 2015?
Breast
; 24 Suppl 2: S41-3, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26255199
16.
A community-based model of rapid autopsy in end-stage cancer patients.
Nat Biotechnol
; 34(10): 1010-1014, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27617737